Technical Analysis for ACHV - Achieve Life Sciences, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Overbought Stochastic | Strength | 0.00% | |
Up 3 Days in a Row | Strength | 0.00% | |
Up 4 Days in a Row | Strength | 0.00% | |
50 DMA Support | Bullish | 0.22% | |
Pocket Pivot | Bullish Swing Setup | 0.22% | |
Volume Surge | Other | 0.22% | |
Stochastic Reached Overbought | Strength | 0.22% | |
Earnings Movers | Other | 0.22% | |
Weak + Overbought | Other | 0.22% | |
Overbought Stochastic | Strength | 0.22% |
Alert | Time |
---|---|
Down 2 % | about 8 hours ago |
Up 2% | about 8 hours ago |
60 Minute Opening Range Breakdown | about 12 hours ago |
Down 1% | about 12 hours ago |
Rose Above Previous Day's High | about 14 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/14/2024
Achieve Life Sciences, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. It is developing Apatorsen to block the production of heat shock protein 27, a cell-survival protein expressed in various types of cancers, including bladder, prostate, breast, pancreatic, and non-small cell lung cancer. The company is headquartered in Bothell, Washington.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Breast Cancer Prostate Cancer Non Small Cell Lung Cancer Treatment Of Breast Cancer Small Cell Lung Cancer Oncolytics Biotech Apatorsen
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Breast Cancer Prostate Cancer Non Small Cell Lung Cancer Treatment Of Breast Cancer Small Cell Lung Cancer Oncolytics Biotech Apatorsen
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 10.25 |
52 Week Low | 3.03 |
Average Volume | 97,465 |
200-Day Moving Average | 4.75 |
50-Day Moving Average | 4.43 |
20-Day Moving Average | 4.30 |
10-Day Moving Average | 4.44 |
Average True Range | 0.24 |
RSI (14) | 57.26 |
ADX | 13.88 |
+DI | 23.28 |
-DI | 13.62 |
Chandelier Exit (Long, 3 ATRs) | 3.96 |
Chandelier Exit (Short, 3 ATRs) | 4.55 |
Upper Bollinger Bands | 4.75 |
Lower Bollinger Band | 3.86 |
Percent B (%b) | 0.83 |
BandWidth | 20.56 |
MACD Line | 0.03 |
MACD Signal Line | 0.00 |
MACD Histogram | 0.0372 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 4.90 | ||||
Resistance 3 (R3) | 4.90 | 4.79 | 4.85 | ||
Resistance 2 (R2) | 4.79 | 4.72 | 4.80 | 4.83 | |
Resistance 1 (R1) | 4.70 | 4.67 | 4.75 | 4.70 | 4.82 |
Pivot Point | 4.59 | 4.59 | 4.62 | 4.60 | 4.59 |
Support 1 (S1) | 4.50 | 4.52 | 4.55 | 4.50 | 4.38 |
Support 2 (S2) | 4.39 | 4.47 | 4.40 | 4.37 | |
Support 3 (S3) | 4.30 | 4.39 | 4.35 | ||
Support 4 (S4) | 4.30 |